|
MechanismTop II inhibitors |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCCKB antagonists |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Yamanouchi Pharmaceutical Co. Ltd. /Over-the-Counter Phar Bus
0 Patents (Medical) associated with Yamanouchi Pharmaceutical Co. Ltd. /Over-the-Counter Phar Bus
100 Deals associated with Yamanouchi Pharmaceutical Co. Ltd. /Over-the-Counter Phar Bus
100 Translational Medicine associated with Yamanouchi Pharmaceutical Co. Ltd. /Over-the-Counter Phar Bus